@FiercePharma: Patients 'waiting up to nine years' for NICE to approve drugs, a U.K. study finds--Telegraph. Story | Follow @FiercePharma
> Pfizer ($PFE) said its kidney cancer drug Torisel failed to beat Bayer's Nexavar at improving progression-free survival in a phase III trial. Nexavar bested Torisel on overall survival, the study's secondary endpoint. Report
> Merck KGaA's colorectal cancer drug Erbitux failed a late-stage trial as an add-on to standard chemotherapy in the adjuvant setting. Article
> Bristol-Myers Squibb ($BMY) won FDA approval for a new plant in Massachusetts, where it will produce its rheumatoid arthritis drug Orencia. Item
> Pfizer plans to cut about 50 jobs at an estrogen-extraction facility in Canada, where the company processes the hormone for its Premarin menopause drug. News
> Novartis ($NVS) sued Indian genericsmakers Lupin and Torrent Pharmaceuticals for patent infringement to block copycat versions of its Exforge HCT blood pressure drug. More
> Piramal Healthcare agreed to buy Decision Resources, a data and services provider, for $635 million. Story
> Cardinal Health agreed to shut down the distribution of controlled substances at a Florida warehouse for two years to settle Drug Enforcement Agency allegations. Report
Biotech News
@FierceBiotech: MIT: Staggering cancer drugs can make them more effective. More | Follow @FierceBiotech
@RyanMFierce: It's only a matter of time before fat taxes are everywhere. Obesity costs too much, and taxes on smokes paved the way. Report | Follow @RyanMFierce
@JohnCFierce: Stealth no more: Ra Pharma in Cambridge nails $8.6M venture tranche, targets hereditary angioedema for the lead. Article | Follow @JohnCFierce
> Elevation boasts 'gold standard' IIb data for COPD therapy. Item
> Achillion burnishes buyout prospects, snags fast track for hep C drug. News
> Cancer drug experts brace for ASCO abstract dump tonight. Report
Medical Device News
@FierceMedDev: Folks, the clock is ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev
> NeuroSigma buys patents that advance TFN stents. Report
> OraSure's OTC HIV test wins crucial FDA panel backing. Article
> Medtronic's Resolute Integrity stent gains CE mark for 7 new indications. More
> St. Jude wins CE mark for hypertension treatment device. Item
Drug Delivery News
@DamianFierce: Using self-assembling DNA tubes, Harvard researchers plan to effectively deliver drugs to cells. News | Follow @DamianFierce
> UNC researchers craft siRNA platform that can switch its solubility. Report
> MIT: Staggering cancer drugs can make them more effective. Story
> Japanese firm buys Altea's assets, plans to launch transdermal tech. Article
> D. Medical signs worldwide marketing deal for insulin-delivery tech. Item
Biomarkers News
> Genes tag schizophrenia risk. More
> Proteins in a drop of fluid mark osteoarthritis risk. Report
> Early pancreatic biomarker could spot killer disease. Article
> Gene IDs fast-onset Parkinson's disease. Story
And Finally... The World Health Organization warned that chronic diseases common in rich nations are spreading rapidly in the developing world. Report